No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs192688305 |
chr7:4509022-4509023 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs569866394 |
chr7:4509033-4509034 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs538781767 |
chr7:4509047-4509048 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs150094933 |
chr7:4509082-4509083 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs565681304 |
chr7:4509083-4509084 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs375635209 |
chr7:4509095-4509096 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs534292914 |
chr7:4509150-4509151 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs200585246 |
chr7:4509209-4509210 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs554204624 |
chr7:4509236-4509237 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs182998523 |
chr7:4509241-4509242 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs574283329 |
chr7:4509261-4509262 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs138642676 |
chr7:4509291-4509292 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs186670520 |
chr7:4509306-4509307 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs10216034 |
chr7:4509319-4509320 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs545107534 |
chr7:4509328-4509329 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs192558299 |
chr7:4509347-4509348 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs371479019 |
chr7:4509367-4509368 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs527695580 |
chr7:4509371-4509372 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs184746833 |
chr7:4509400-4509401 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs189075844 |
chr7:4509411-4509412 |
Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs529993303 |
chr7:4509466-4509467 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs372576369 |
chr7:4509468-4509469 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs550041841 |
chr7:4509516-4509517 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs549477634 |
chr7:4509552-4509553 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs141480664 |
chr7:4509589-4509590 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs532296466 |
chr7:4509613-4509614 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs552321456 |
chr7:4509614-4509615 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs565744190 |
chr7:4509620-4509621 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs147009216 |
chr7:4509622-4509623 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs77985864 |
chr7:4509627-4509628 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs138159720 |
chr7:4509649-4509650 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs536582677 |
chr7:4509656-4509657 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs556398184 |
chr7:4509657-4509658 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs1466067 |
chr7:4509658-4509659 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
35 |
rs12155305 |
chr7:4509683-4509684 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
36 |
rs149511921 |
chr7:4509696-4509697 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572477175 |
chr7:4509742-4509743 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs118179336 |
chr7:4509788-4509789 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs193200120 |
chr7:4509819-4509820 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs552729538 |
chr7:4509822-4509823 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs530064987 |
chr7:4509825-4509826 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs116304932 |
chr7:4509838-4509839 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs563755251 |
chr7:4509845-4509846 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs563544549 |
chr7:4509850-4509851 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs532361182 |
chr7:4509859-4509860 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs552432553 |
chr7:4509869-4509870 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs143999568 |
chr7:4509896-4509897 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs530921423 |
chr7:4509897-4509898 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs548258796 |
chr7:4509900-4509901 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs2343281 |
chr7:4509912-4509913 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|